Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

被引：0
作者：
Robert M. Anthenelli
Michael Gaffney
Neal L. Benowitz
Robert West
Thomas McRae
Cristina Russ
David Lawrence
Lisa St. Aubin
Alok Krishen
A. Eden Evins
机构：
[1] University of California,Department of Psychiatry
[2] San Diego,Department of Medicine
[3] Pfizer,undefined
[4] University of California,undefined
[5] University College,undefined
[6] PAREXEL International on behalf of GlaxoSmithKline,undefined
[7] Massachusetts General Hospital and Harvard Medical School,undefined
来源：
Journal of General Internal Medicine | 2019年 / 34卷
关键词：
neuropsychiatric adverse event; smoking cessation medication; varenicline; predictors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：862 / 870
页数：8
相关论文
共 50 条
  • [21] Behavioral cessation treatment of waterpipe smoking: The first pilot randomized controlled trial
    Asfar, Taghrid
    Al Ali, Radwan
    Rastam, Samer
    Maziak, Wasim
    Ward, Kenneth D.
    ADDICTIVE BEHAVIORS, 2014, 39 (06) : 1066 - 1074
  • [22] A Randomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacotherapies
    Piper, Megan E.
    Smith, Stevens S.
    Schlam, Tanya R.
    Fiore, Michael C.
    Jorenby, Douglas E.
    Fraser, David
    Baker, Timothy B.
    ARCHIVES OF GENERAL PSYCHIATRY, 2009, 66 (11) : 1253 - 1262
  • [23] Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
    Josep M Ramon
    Sergio Morchon
    Antoni Baena
    Cristina Masuet-Aumatell
    BMC Medicine, 12
  • [24] Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial
    Lindson-Hawley, Nicola
    Coleman, Tim
    Docherty, Graeme
    Hajek, Peter
    Lewis, Sarah
    Lycett, Deborah
    McEwen, Andy
    McRobbie, Hayden
    Munafo, Marcus R.
    Parrott, Steve
    Aveyard, Paul
    TRIALS, 2014, 15
  • [25] Risk of neuropsychiatric adverse events associated with varenicline treatment for smoking cessation among Dutch population: A sequence symmetry analysis
    Wang, Yuanyuan
    van Boven, Job F. M.
    Bos, Jens H. J.
    Schuiling-Veninga, Catharina C. M.
    Boezen, H. Marike
    Wilffert, Bob
    Hak, Eelko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (02) : 158 - 166
  • [26] Cytisinicline for Smoking Cessation A Randomized Clinical Trial
    Rigotti, Nancy A.
    Benowitz, Neal L.
    Prochaska, Judith
    Leischow, Scott
    Nides, Mitchell
    Blumenstein, Brent
    Clarke, Anthony
    Cain, Daniel
    Jacobs, Cindy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 152 - 160
  • [27] Cardiovascular Adverse Events Associated with Smoking-Cessation Pharmacotherapies
    Abhishek Sharma
    Saurabh Thakar
    Carl J. Lavie
    Jalaj Garg
    Parasuram Krishnamoorthy
    Ondrej Sochor
    Armin Arbab-Zadeh
    Edgar Lichstein
    Current Cardiology Reports, 2015, 17
  • [28] Cardiovascular Adverse Events Associated with Smoking-Cessation Pharmacotherapies
    Sharma, Abhishek
    Thakar, Saurabh
    Lavie, Carl J.
    Garg, Jalaj
    Krishnamoorthy, Parasuram
    Sochor, Ondrej
    Arbab-Zadeh, Armin
    Lichstein, Edgar
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (01)
  • [29] Do tobacco regulatory and economic factors influence smoking cessation outcomes? A post-hoc analysis of the multinational EAGLES randomised controlled trial
    Daniel, Belinda
    Lawrence, David E.
    McKenna, Benjamin S.
    Saccone, Phillip
    McRae, Thomas
    Evins, A. Eden
    Anthenelli, Robert M.
    BMJ OPEN, 2024, 14 (09):
  • [30] Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo
    Rae A. Littlewood
    Eric D. Claus
    Claire E. Wilcox
    Jessica Mickey
    Pamela B. Arenella
    Angela D. Bryan
    Kent E. Hutchison
    Psychopharmacology, 2017, 234 : 3417 - 3429
12345